EBI-005 is Clinical Candidate for Treating Dry Eye Disease with Potential in Other Ocular Surface Inflammatory Diseases

Data Presented at ARVO 2013 Annual Meeting Demonstrated EBI-005 is Safe and Well-Tolerated

CAMBRIDGE, Mass.--(BUSINESS WIRE)--

Selventa today announced that it has been granted United States patent (No. No 8,417,661) titled “Method for Quantifying Amplitude of a Response of a Biological Network.” This patent is core to Selventa’s SysDx™ approach to mining and comparing biological data for predicting a patient’s response or non-response to a drug.

TRENTON, N.J. and WALTHAM, May 08, 2013 (GLOBE NEWSWIRE via COMTEX) -- The Trenton Health Team (THT) and BG Medicine BGMD today announced that THT has adopted the BGM Galectin-3(R) test throughout its organization to identify patients at near term risk for heart failure rehospitalization.

LEXINGTON, Mass., May 06, 2013 (BUSINESS WIRE) -- Concert Pharmaceuticals, Inc. today announced that it has entered into a strategic collaboration with Celgene Corporation directed towards deuterium-modified compounds targeting cancer and inflammation. The collaboration will initially focus on one program, but has the potential to encompass multiple targets.

CAMBRIDGE, Mass., April 30, 2013 /PRNewswire/ -- Moderna Therapeutics, the pioneering company developing messenger RNA therapeutics™—a revolutionary new treatment modality to enable the in vivo production of therapeutic proteins—announced today that Henri A.

Andover, Massachusetts - April 25, 2013

Interim results from the International INSPIRE Trial presented today at the International Society for Heart and Lung Transplantation (ISHLT) 33^rd Annual Meeting in Montreal, are indicating significant improvement in post-lung transplant clinical outcomes using the TransMedics Organ Care System (OCS) Lung portable perfusion and ventilation system.

Breakthrough approach to rapid detection of Candida species directly from whole blood with T2 Magnetic resonance demonstrated in first patient samples

Joins Global Companies Recognized as Leaders in the Transformation of the Energy Sector

Bedford, MA – April 23, 2013 – Joule today announced its selection as a 2013 Bloomberg New Energy Pioneer, an annual award that recognizes game-changing companies in the field of clean energy. Joule was one of ten companies chosen from among hundreds of applicants, and was recognized yesterday at the Bloomberg New Energy Finance Summit in New York City.

Combination of first-in-class multiplex PCR and Systems Diagnostics (SysDx™) technologies to open new opportunities for high value MoDx in major disease areas